No profile data available.
Cencora, Inc. (COR) is a healthcare company in the additional drug wholesale industry, based in Conshohocken, United States, with about 47,000 full-time employees.
It reported revenue of $321.33 billion for fiscal year 2025, up 9.3% from fiscal year 2024, and net income of $1.55 billion. In Q3 2026 (the quarter ended June 30, 2026) revenue was $84.75 billion, up 5.1% from a year before. Its largest business segment, U.S. Healthcare Solutions, brought in 91% of segment revenue in fiscal year 2025. Its market capitalization was $61.80 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended September 30, 2025; market data as of October 9, 2026.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. S.
Cencora reported $321.33 billion in revenue for fiscal year 2025, up 9.3% from $293.96 billion in fiscal year 2024. In Q3 2026 revenue was $84.75 billion.
U.S. Healthcare Solutions, with $290.98 billion or 91% of segment revenue in fiscal year 2025. Next: International Healthcare Solutions (9%).
$61.80 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (additional drug wholesale) include McKesson Corporation (MCK), Cardinal Health, Inc. (CAH), BrightSpring Health Services, Inc. (BTSG), Harrow, Inc. (HROW).